September 01, 2011|
Thermo Fisher Scientific acquires Intrinsic Bioprobes Inc.
April 19, 2011
Intrinsic Bioprobes launches three new CLIA approved mass spectrometry-based tests for proteins implicated in kidney disease and renal failure.
July 15, 2010
Intrinsic Bioprobes announces an Alliance with Thermo Fisher Scientific in Mass Spectrometric Immunoassay (MSIA) workflow development.
January 21, 2010
Intrinsic Bioprobes announces the discovery and exclusive licensing of novel biomarkers for diabetes.
March 31, 2009
IBI enters into a 1.27M contract with NCI to develop Multiplex Mass Spectrometric Immunoassays for detection of low abundance cancer related proteins.
October 16, 2008
IBI develops novel mass spectrometry-based assay that reveals degradation and low levels of bioactive B-type Natriuretic Peptide (BNP)
in patients with heart failure.
More IBI news >>